Silicon Valley Bank’s Failure Rattles Investors In Biopharma Sector

 
• By Alaric DeArment

Investment bank analysts, VC funds and biopharma companies all sought to calm investors’ nerves as a go-to financial institution for tech and biotech collapsed.

Investors were rattled as Silicon Valley Bank, which long served biotech as well as technology companies, failed on 10 March • Source: Shutterstock

More from Financing

More from Business